Although standard INF-α was used in some CHC patients in two studies [29], [30], the results from the other four trials showed that antidepressants markedly decreased the incidence of depression to 17.2% during PEG-IFN-α-based antiviral therapy. This evidence concerns the gene IFNA1 and major depressive disorder.